These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10704462)

  • 1. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
    Obst R; Netuschil N; Klopfer K; Stevanović S; Rammensee HG
    J Exp Med; 2000 Mar; 191(5):805-12. PubMed ID: 10704462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive selection of the T-cell repertoire is affected by mutations in the peptide-binding site of MHC class I molecules.
    Nikolić-Zugić J; Dyall R
    Ann N Y Acad Sci; 1993 Jun; 681():16-24. PubMed ID: 8395147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide dependency of alloreactive CD4+ T cell responses.
    Mendiratta SK; Kovalik JP; Hong S; Singh N; Martin WD; Van Kaer L
    Int Immunol; 1999 Mar; 11(3):351-60. PubMed ID: 10221647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire.
    Obst R; Münz C; Stevanović S; Rammensee HG
    Eur J Immunol; 1998 Aug; 28(8):2432-43. PubMed ID: 9710221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of the T-cell repertoire during ontogeny.
    von Boehmer H; Bennink J; Teh HS; Haas W
    Ann Immunol (Paris); 1983; 134D(1):17-24. PubMed ID: 6194740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
    Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
    Dal Porto J; Johansen TE; Catipović B; Parfiit DJ; Tuveson D; Gether U; Kozlowski S; Fearon DT; Schneck JP
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6671-5. PubMed ID: 8341685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells.
    Malarkannan S; Afkarian M; Shastri N
    J Exp Med; 1995 Dec; 182(6):1739-50. PubMed ID: 7500018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally processed mitochondrial self-peptide in complex with thymic MHC molecules functions as a selecting ligand for a viral-specific T cell receptor.
    Sasada T; Ghendler Y; Neveu JM; Lane WS; Reinherz EL
    J Exp Med; 2001 Oct; 194(7):883-92. PubMed ID: 11581311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands.
    Ghendler Y; Teng MK; Liu JH; Witte T; Liu J; Kim KS; Kern P; Chang HC; Wang JH; Reinherz EL
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10061-6. PubMed ID: 9707600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.
    Chattopadhyay S; Theobald M; Biggs J; Sherman LA
    J Exp Med; 1994 Jan; 179(1):213-9. PubMed ID: 8270866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.
    Brock R; Wiesmüller KH; Jung G; Walden P
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13108-13. PubMed ID: 8917552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.